← back to database
Disciplined, data-driven biotechnology investing focused on transformative therapeutics that can improve standards of care.
Stage focus
Lead / follow
Specialization
Generalist / Specialist
Specialist
Investing team
Arsani WilliamManaging Partner & Chief Investment Officer
Brandon AdamsAnalyst
Graham WalmsleyManaging Partner
Jesse YuSenior Analyst
Yuqi WangSenior Analyst